Lectus Therapeutics Overview
- Year Founded
-
2002

- Status
-
Acquired/Merged
- Employees
-
4

- Latest Deal Type
-
M&A
- Investors
-
1
Lectus Therapeutics General Information
Description
Operator of a drug discovery and development company intended to focus on next-generation ion channel modulators. The company offers ion-channel modulators for a range of illnesses including angina, asthma, epilepsy urinary bladder disorders and more.
Contact Information
Website
www.lectustherapeutics.comCorporate Office
- PO Box 2299
- Bristol BS99 5YG
- England, United Kingdom
Corporate Office
- PO Box 2299
- Bristol BS99 5YG
- England, United Kingdom
Lectus Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 22-Nov-2011 | Completed | Generating Revenue | |||
5. Later Stage VC | 05-Sep-2007 | Completed | Startup | |||
4. Early Stage VC (Series A) | 13-Feb-2006 | Completed | Startup | |||
3. Early Stage VC | 06-May-2004 | Completed | Startup | |||
2. Seed Round | 03-Nov-2003 | Completed | Startup | |||
1. University Spin-Out | 15-Oct-2002 | Completed |
Lectus Therapeutics Patents
Lectus Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-0817576-D0 | Calcium ion channel modulators & uses thereof | Inactive | 25-Sep-2008 | ||
GB-0814076-D0 | Ion channel modulator combinations and uses thereof | Inactive | 01-Aug-2008 | ||
GB-0813403-D0 | Potassium ion channel modulators & uses thereof | Inactive | 22-Jul-2008 | ||
AU-2009265292-A1 | Calcium ion channel modulators and uses thereof | Inactive | 03-Jul-2008 | ||
CA-2729688-A1 | Calcium ion channel modulators & uses thereof | Inactive | 03-Jul-2008 | C07D491/056 |
Lectus Therapeutics Signals
Lectus Therapeutics Former Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Astellas Venture Management | Corporate Venture Capital | Minority | ||
Questar Assessment | Corporation | Minority | ||
Quester (Private Equity) | Venture Capital | Minority | ||
Rockwood Strategic | Hedge Fund | Minority | ||
Sofinnova Partners | Venture Capital | Minority |
Lectus Therapeutics Acquisitions (1)
Lectus Therapeutics’s most recent deal was a Merger/Acquisition with NeuroServe. The deal was made on 19-Apr-2006.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
NeuroServe | 19-Apr-2006 | Merger/Acquisition | Other Healthcare Technology Systems |
Lectus Therapeutics FAQs
-
When was Lectus Therapeutics founded?
Lectus Therapeutics was founded in 2002.
-
Where is Lectus Therapeutics headquartered?
Lectus Therapeutics is headquartered in Bristol, United Kingdom.
-
What is the size of Lectus Therapeutics?
Lectus Therapeutics has 4 total employees.
-
What industry is Lectus Therapeutics in?
Lectus Therapeutics’s primary industry is Drug Discovery.
-
Is Lectus Therapeutics a private or public company?
Lectus Therapeutics is a Private company.
-
What is Lectus Therapeutics’s current revenue?
The current revenue for Lectus Therapeutics is
. -
How much funding has Lectus Therapeutics raised over time?
Lectus Therapeutics has raised $14M.
-
Who are Lectus Therapeutics’s investors?
Astellas Venture Management, Questar Assessment, Quester (Private Equity), Rockwood Strategic, and Sofinnova Partners are 5 of 7 investors who have invested in Lectus Therapeutics.
-
When was Lectus Therapeutics acquired?
Lectus Therapeutics was acquired on 22-Nov-2011.
-
Who acquired Lectus Therapeutics?
Lectus Therapeutics was acquired by UCB Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »